FDA issues health advisory on Medtronic stent

Patients who were treated for abdominal aortic aneurysm with Medtronic's AneuRx stent-graft system had higher death rates after five years compared with those who underwent conventional surgery, the FDA said in a public-health notice. A company spokesman said that the FDA's data leave out information about short-term mortality and that the device "performs better compared to open surgery in late AAA-related deaths."

View Full Article in:

Wall Street Journal (free content), The · Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN